Hozefa A Divan – Boston Collaborative Drug Surveillance Program (BCDSP)

Risk of Incident Antidepressant-Treated Depression Associated with Use of 5α-Reductase Inhibitors Compared with Use of α-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink

By BCDSP May 2, 2017Uncategorized

Journal: Pharmacotherapy Authors: Katrina Wilcox Hagberg 1, Hozefa A Divan 2, J Curtis Nickel 3, Susan S Jick 1 NLM Citation: Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of Incident Antidepressant-Treated Depression Associated with Use…

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

By BCDSP February 10, 2017Drug Safety Studies, Safety of other important drugs, Select Publications

Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Hozefa A Divan, Shona C Fang, J Curtis Nickel, Susan S Jick 1 NLM Citation: Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS. Risk of gynecomastia…

Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink

By BCDSP September 22, 2016Drug Safety Studies, Safety of other important drugs, Select Publications

Journal: BMJ (Clinical research ed.) Authors: Katrina Wilcox Hagberg, Hozefa A Divan, Rebecca Persson, J Curtis Nickel, Susan S Jick NLM Citation: Hagberg KW, Divan HA, Persson R, Nickel JC, Jick SS. Risk of…